Koo JS - Search Results

1

Breast cancers presenting luminal B subtype features show higher discordant human epidermal growth factor receptor 2 results between immunohistochemistry and fluorescence in situ hybridization.

Park S, Park HS, Koo JS, Yang WI, Kim SI, Park BW. Park S, et al. Among authors: koo js. Cancer. 2012 Feb 15;118(4):914-23. doi: 10.1002/cncr.26406. Epub 2011 Jul 28. Cancer. 2012. PMID: 21800290 Free article.

2

Immunological aspects in patients with chronic active hepatitis--cellular immune responses.

Park B, Koo J, De Groote J. Park B, et al. J Korean Med Sci. 1986 Sep;1(1):15-23. doi: 10.3346/jkms.1986.1.1.15. J Korean Med Sci. 1986. PMID: 2856581 Free PMC article.

3

Clinicopathological characteristics of male breast cancer.

Park S, Kim JH, Koo J, Park BW, Lee KS. Park S, et al. Yonsei Med J. 2008 Dec 31;49(6):978-86. doi: 10.3349/ymj.2008.49.6.978. Yonsei Med J. 2008. PMID: 19108022 Free PMC article.

4

HER-2 protein overexpressing breast cancer without gene amplification shows higher hormone receptor expression than HER-2 protein overexpressing breast cancer with gene amplification.

Koo JS, Jung W, Yang WI. Koo JS, et al. Int J Surg Pathol. 2011 Aug;19(4):425-32. doi: 10.1177/1066896909335821. Epub 2009 Aug 10. Int J Surg Pathol. 2011. PMID: 19666946

5

Impact of grade, hormone receptor, and HER-2 status in women with breast cancer on response to specific chemotherapeutic agents by in vitro adenosine triphosphate-based chemotherapy response assay.

Koo JS, Jung W, Shin E, Lee HD, Jeong J, Kim KH, Jeong H, Hong SW. Koo JS, et al. J Korean Med Sci. 2009 Dec;24(6):1150-7. doi: 10.3346/jkms.2009.24.6.1150. Epub 2009 Nov 9. J Korean Med Sci. 2009. PMID: 19949674 Free PMC article.

6

Paclitaxel combined with ifosfamide in anthracycline- and docetaxel-pretreated metastatic breast cancer: activity independence of prior docetaxel resistance.

Moon YW, Sohn JH, Choi HJ, Chang H, Park BW, Kim SI, Park S, Koo JS, Kim YT, Roh JK, Chung HC, Kim JH. Moon YW, et al. Among authors: koo js. Cancer Chemother Pharmacol. 2010 Aug;66(3):425-31. doi: 10.1007/s00280-009-1176-5. Epub 2009 Dec 15. Cancer Chemother Pharmacol. 2010. PMID: 20012956

7

Clinicopathological characteristics of mucinous carcinoma of the breast in Korea: comparison with invasive ductal carcinoma-not otherwise specified.

Park S, Koo J, Kim JH, Yang WI, Park BW, Lee KS. Park S, et al. J Korean Med Sci. 2010 Mar;25(3):361-8. doi: 10.3346/jkms.2010.25.3.361. Epub 2010 Feb 19. J Korean Med Sci. 2010. PMID: 20191033 Free PMC article.

8

Metastatic breast cancer shows different immunohistochemical phenotype according to metastatic site.

Koo JS, Jung W, Jeong J. Koo JS, et al. Tumori. 2010 May-Jun;96(3):424-32. doi: 10.1177/030089161009600308. Tumori. 2010. PMID: 20845803

9

Immunohistochemical characteristics of diffuse sclerosing variant of papillary carcinoma: comparison with conventional papillary carcinoma.

Koo JS, Shin E, Hong SW. Koo JS, et al. APMIS. 2010 Oct;118(10):744-52. doi: 10.1111/j.1600-0463.2010.02653.x. APMIS. 2010. PMID: 20854468

10

Clinicopathlogic and immunohistochemical characteristics of triple negative invasive lobular carcinoma.

Koo JS, Jung W. Koo JS, et al. Yonsei Med J. 2011 Jan;52(1):89-97. doi: 10.3349/ymj.2011.52.1.89. Yonsei Med J. 2011. PMID: 21155040 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

443 results

Search Page

Filters